Meeting
2019 ASCO Annual Meeting
Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally-advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy.
Authors
Marc Oliva Bernal
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
Marc Oliva Bernal , Shao Hui Huang , Rachel Taylor , Jie Su , Wei Xu , Aaron Richard Hansen , Raymond Woo-Jun Jang , Andrew Bayley , Ali Hosni , Meredith Elana Giuliani , Jolie Ringash , Scott Victor Bratman , John Cho , Jonathan Crawford Irish , John Waldron , Ilan Weinreb , John Kim , Brian O'Sullivan , Lillian L. Siu , Anna Spreafico
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6046)
DOI
10.1200/JCO.2019.37.15_suppl.6046
Abstract #
6046
Poster Bd #
35
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Predictive values of (18)f-FDG PET standardized uptake value for adjuvant chemotherapy in patients with nasopharyngeal carcinoma.
First Author: Ching Chan Lin
Poster
2011 ASCO Annual Meeting
Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer.
First Author: J. J. Caudell
Poster
2020 ASCO Virtual Scientific Program
Final results of a phase III randomized trial of comparison of three paclitaxel-based regimens concurrent with radiotherapy for patients with local advanced esophageal squamous cell carcinoma.
First Author: Dashan Ai
Poster
2019 ASCO Annual Meeting
TENERGY: Multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy with 5-FU plus cisplatin in patients with locally advanced esophageal squamous cell carcinoma.
First Author: Hideaki Bando